Vivek K Mehta

Summary

Publications

  1. ncbi Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil, and weekly CPT-11, followed by surgery for ultrasound-staged T3 rectal cancer
    Vivek K Mehta
    Department of Radiation Oncology, Stanford University Medical Center, Stanford, CA, USA
    Int J Radiat Oncol Biol Phys 55:132-7. 2003
  2. ncbi Image guided stereotactic radiosurgery for lesions in proximity to the anterior visual pathways: a preliminary report
    Vivek K Mehta
    Department of Radiation Oncology, Stanford University Medical Center, Stanford, CA 94305, USA
    Technol Cancer Res Treat 1:173-80. 2002
  3. ncbi Postmastectomy radiation therapy after TRAM flap breast reconstruction
    Vivek K Mehta
    Department of Radiation Oncology, Stanford University Medical Center, Stanford, California, USA
    Breast J 10:118-22. 2004
  4. ncbi Experience with an electronic brachytherapy technique for intracavitary accelerated partial breast irradiation
    Vivek K Mehta
    Department of Radiation Oncology, Swedish Cancer Institute, Seattle, WA 98104, USA
    Am J Clin Oncol 33:327-35. 2010
  5. ncbi Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer
    Albert C Koong
    Department of Radiation Oncology, Stanford University, Stanford, California 94305 5152, USA
    Int J Radiat Oncol Biol Phys 58:1017-21. 2004

Detail Information

Publications5

  1. ncbi Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil, and weekly CPT-11, followed by surgery for ultrasound-staged T3 rectal cancer
    Vivek K Mehta
    Department of Radiation Oncology, Stanford University Medical Center, Stanford, CA, USA
    Int J Radiat Oncol Biol Phys 55:132-7. 2003
    ..We report the results from a Phase II trial of preoperative radiotherapy (RT), CPT-11, and 5-FU for patients with ultrasound-staged T3 rectal cancer...
  2. ncbi Image guided stereotactic radiosurgery for lesions in proximity to the anterior visual pathways: a preliminary report
    Vivek K Mehta
    Department of Radiation Oncology, Stanford University Medical Center, Stanford, CA 94305, USA
    Technol Cancer Res Treat 1:173-80. 2002
    ..Fractionated SRS using the CyberKnife is technically feasible and may decrease the risk of optic neuropathy. Greater patient accrual and longer follow up will be necessary to further determine the clinical benefit of this approach...
  3. ncbi Postmastectomy radiation therapy after TRAM flap breast reconstruction
    Vivek K Mehta
    Department of Radiation Oncology, Stanford University Medical Center, Stanford, California, USA
    Breast J 10:118-22. 2004
    ..The acute toxicity was manageable. There were no TRAM flap losses or revisions performed secondary to the radiotherapy...
  4. ncbi Experience with an electronic brachytherapy technique for intracavitary accelerated partial breast irradiation
    Vivek K Mehta
    Department of Radiation Oncology, Swedish Cancer Institute, Seattle, WA 98104, USA
    Am J Clin Oncol 33:327-35. 2010
    ..Phase IV study evaluated the safety and device performance of an electronic brachytherapy system (Axxent Electronic Brachytherapy System) as adjuvant therapy for early-stage breast cancer...
  5. ncbi Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer
    Albert C Koong
    Department of Radiation Oncology, Stanford University, Stanford, California 94305 5152, USA
    Int J Radiat Oncol Biol Phys 58:1017-21. 2004
    ..To determine the feasibility and toxicity of delivering stereotactic radiosurgery to patients with locally advanced pancreatic cancer...